Updated Phase 3 data analyzing the Pfizer-BioNTech COVID-19 vaccine up to six months after second vaccination showed it was 91.3% effective overall and 100% effective versus severe disease.
The Novavax vaccine is the fifth COVID-19 vaccine candidate to begin clinical trials, after Pfizer/BioNTech, Moderna, AstraZeneca, and Johnson & Johnson.
A phase 3 study of inhaled molgramostim therapy found the drug resulted in greater improvements in pulmonary gas transfer and functional health status than placebo in patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP).
This clinical trial will monitor patients with mild to moderate cases of COVID-19 to see how they respond to inhaled nitric oxide as a treatment.
Read More
Early treatment with the antiviral drug remdesivir significantly reduced clinical disease and damage to the lungs of rhesus macaques infected with SARS-CoV-2.
Read More
The first clinical results for remdesivir’s effectiveness on severe COVID-19 demonstrated clinical improvements but remain unclear because no control group was included in the study.
Read More
Bellerophon Therapeutics will soon initiate a Phase 3 trial for its INOpulse inhaled nitric oxide therapy for the treatment of pulmonary hypertension associated with pulmonary fibrosis.
Read More
Acceleron Pharma’s investigational treatment for pulmonary arterial hypertension showed positive outcomes in a mid-stage trial, the company announced on Monday.
Read More
Sickle cell disease patients receiving Oxbryta (1500mg) experienced a 51.1% increase in hemoglobin response rate compared to 6.5% in the placebo group.
Read More
An experimental universal flu vaccine is being administered to patients as part of a clinical drug trial at the National Institutes of Health, reports CNN.
Read More
Novavax has initiated a Phase 3 clinical trial for NanoFlu, its recombinant quadrivalent seasonal influenza vaccine candidate, in adults aged 65 and over.
Read More
Orkambi appeared to improve lung function and body weight and reduce the need for intravenous antibiotic treatment in adult and pediatric cystic fibrosis patients, but 18% of patients did not tolerate the therapy.
Read More
A 12-month feasibility study of the RejuvenAir Metered Cryospray system revealed “clinically meaningful improvements” in COPD patients with chronic bronchitis.
Read MoreAn unlikely bidding war has erupted over a former tuberculosis sanatorium in upstate New York that has been abandoned for nearly half a century, reports Fox News. In recent days, online haggling for Saratoga County Homestead in...
Read More
More complex studies that integrate multiple layers of asthma data have begun, but additional work is needed.
Read More